✦ LIBER ✦

Adverse Effects of Bevacizumab and Their Management in Solid Tumors

✍ Scribed by Arriaga, Yull; Becerra, Carlos R.

Book ID: 122785501
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 105 KB
Volume: 3
Category: Article
ISSN: 1543-2912
DOI: 10.3816/SCT.2006.n.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances and management of solid tumors

Advances and management of solid tumors in children

✍ Mark E. Nesbit Jr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 671 KB

A phase I study of bevacizumab, everolim

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors

✍ Vlahovic, Gordana; Meadows, Kellen L.; Uronis, Hope E.; Morse, Michael A.; Blobe 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 187 KB

Phase I study of capecitabine, oxaliplat

Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors

✍ Rangwala, Fatima; Bendell, Johanna C.; Kozloff, Mark F.; Arrowood, Christy C.; D 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 352 KB

Rate of serious adverse effects in a ser

Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections

✍ Sharma, Sanjay; Johnson, Davin; Abouammoh, Marwan; Hollands, Simon; Brissette, A 📂 Article 📅 2012 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 181 KB

Bevacizumab in the Treatment of Metastat

Bevacizumab in the Treatment of Metastatic Colorectal Cancer: Safety Profile and Management of Adverse Events

✍ Herbert Hurwitz; Shermini Saini 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Phase I study of cetuximab, erlotinib, a

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors

✍ Chia-Chi Lin; Emiliano Calvo; Kyriakos P. Papadopoulos; Amita Patnaik; John Sara 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 278 KB